Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$301,716
-$86,171 QoQ
Shares Held
1,199
-58.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#3,624
of 4,153 holders
Holding Since
Jun 2023
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Intelligence Driven Advisers, LLC holds $3,819,773 across 7 Drug Manufacturers - General names. ABBV ranks #6 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
9,720 | $1,249,020 | |
| 2 | LLY |
ELI LILLY & Co
|
661 | $792,823 | |
| 3 | JNJ |
Johnson & Johnson
|
2,018 | $512,511 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,280 | $414,395 | |
| 5 | AMGN |
Amgen Inc
|
890 | $322,286 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
1,199 | $301,716 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,940 | $227,022 |
All Filings in ABBV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $301,716 | 1,199 | Shares | Sole | 2026-08-06 | |
| 2023-06-30 | $387,887 | 2,879 | Shares | Sole | 2023-07-18 | |
| No filing history on record for this holder in this stock. | ||||||